No demonstrable effect of benzathine penicillin on recurrence of rheumatic Fever in pacific island population.
Compliance with secondary antibiotic prophylaxis for acute rheumatic fever (ARF) should decrease the rate of recurrence; however, efficacy in a highly endemic area has not been studied. A retrospective chart review of patients <21 years old with a diagnosis of ARF in the Northern Mariana Islands was performed. Patient compliance with benzathine penicillin G (BPG) prophylaxis was assessed. One hundred forty-four patients with ARF were identified and considered eligible, and the recurrence rate was 38%. Mean level of compliance with BPG was 59% in patients with no recurrence of ARF and 57% in patients with recurrence of ARF. Level of compliance was not shown to be associated with odds of recurrence. There was a trend toward significance (p = 0.06), with those patients who had carditis at the time of diagnosis of ARF having higher odds of recurrence. A remarkably high recurrence rate of ARF was found in this population, but there was no difference in compliance with secondary antibiotic prophylaxis between those with and without recurrence of ARF. These findings stress the need to improve methods of primary prevention and secondary antibiotic prophylaxis for ARF.
Seckeler
Michael D
MD
Division of Cardiology, Department of Pediatrics, University of Virginia, P.O. Box 800386, Charlottesville, VA 22908, USA. ms3ec@hscmail.mcc.virginia.edu
Hoke
Tracey R
TR
Gurka
Matthew J
MJ
Barton
Leslie L
LL
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D019072:Antibiotic Prophylaxis / Q000379:methods*; D002648:Child; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D015994:Incidence; D008297:Male; D008849:Micronesia / Q000453:epidemiology; D010401:Penicillin G Benzathine / Q000627:therapeutic use*; D011159:Population Surveillance; D012189:Retrospective Studies; D012213:Rheumatic Fever / Q000188:drug therapy* / Q000453:epidemiology; D055502:Secondary Prevention; D016896:Treatment Outcome
D000900:Anti-Bacterial Agents; D010401:Penicillin G Benzathine
Pediatr Infect Dis J. 2009 Jan;28(1):13-6
19057463
N Engl J Med. 1955 May 12;252(19):787-92
14370428
Aust N Z J Public Health. 2005 Dec;29(6):521-5
16366062
Pediatrics. 2004 Mar;113(3 Pt 1):e168-72
14993572
S Afr Med J. 1987 Dec 5;72(11):781-3
3686281
Pediatrics. 1996 Jun;97(6 Pt 2):984-8
8637787
Lancet Infect Dis. 2009 Oct;9(10):611-6
19778763
Aust J Rural Health. 2007 Aug;15(4):234-40
17617086
J Pediatr. 2006 Jul;149(1):58-63
16860129
Pediatrics. 1996 Jun;97(6 Pt 2):989-91
8637788
J Am Med Assoc. 1952 Dec 20;150(16):1571-5
12990472
Pediatr Infect Dis J. 1998 Oct;17(10):890-3
9802630
Heart. 2005 Aug;91(8):1019-22
16020588
Pediatrics. 2000 Jun;105(6):1375
10877673
Clin Infect Dis. 1995 Nov;21(5):1220-7
8589146
Pediatrics. 1969 Feb;43(2):173-82
5763855
Br Med J. 1974 Apr 6;2(5909):39-40
4821041
Clin Infect Dis. 2008 Apr 1;46(7):1038-45
18444821
Med J Aust. 2006 May 15;184(10):514-7
16719752
N Z Med J. 2006 Oct 23;119(1243):U2255
17063195
Int J Infect Dis. 2010 Mar;14(3):e226-9
19648043
Lancet Infect Dis. 2005 Nov;5(11):685-94
16253886
MMWR Morb Mortal Wkly Rep. 2003 Feb 14;52(6):106-9
12645840